Ma et al. reported that apolipoprotein E (APOE) ε4 carriers had a significantly lower perfusion density of the retina in the 6-mm Early Treatment of Diabetic Retinopathy Study circle and outer macular ring compared to noncarriers [80]. The gene discussed is APOE; the disease is diabetic retinopathy.